Kailera Therapeutics is a Biotech company based in Boston, MA. It has raised $1.6B in total funding. Latest round: IPO.
Kailera Therapeutics funding overview
Kailera Therapeutics is a Biotech company based in Boston, MA. Kailera Therapeutics has raised $1.6B in total disclosed funding. That places its disclosed total in over $1B. Its most recent disclosed round is an IPO announced in December 2025. The round record for Kailera Therapeutics runs through 2025; nothing later has been disclosed. Investors on record include Atlas Venture, Bain Capital Life Sciences, RTW Investments. 3 distinct backers are named across the disclosed rounds.
Kailera Therapeutics at a glance
Total raised
$1.6B
Latest round
IPO
Latest round date
December 2025
Industry
Biotech
Headquarters
Boston, MA
Notable investors
Atlas Venture, Bain Capital Life Sciences, RTW Investments
Frequently asked about Kailera Therapeutics funding
How much has Kailera Therapeutics raised?
Kailera Therapeutics has raised $1.6B in total disclosed funding across the rounds on record.
Who has invested in Kailera Therapeutics?
Atlas Venture, Bain Capital Life Sciences, RTW Investments are named among the investors backing Kailera Therapeutics.
What was the latest Kailera Therapeutics funding round?
The most recent disclosed round is an IPO, announced in December 2025.
Where is Kailera Therapeutics based?
Kailera Therapeutics is based in Boston, MA.
What sector does Kailera Therapeutics operate in?
Kailera Therapeutics is tracked under Biotech from Boston, MA, with $1.6B in disclosed funding.
When did Kailera Therapeutics last raise?
The last disclosed Kailera Therapeutics round closed in December 2025 at IPO.
Totals shown for Kailera Therapeutics aggregate every disclosed round on file. To see how that compares, browse the Biotech companies in Boston and the investors behind them below.
